Patient Capital Management, LLC

Q3 2026 13F-HR Holdings

Location
Baltimore, MD
Holdings as of
9/30/2026
Date filed
11/12/2026
Form type
13F-HR
Num holdings
41
Total value ($000)
$3,145,733
Net value change ($000)
+95,249 (3.1%)
New positions
3
Sold out positions
3
Turnover %
5.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AVGO 83,743 NEW
PGEN 45,142 41.6%
CHYM 42,422 50.7%
META 35,040 36.4%
FBTC 26,675 42.9%
ADBE 22,037 29.8%
NVDA 20,152 14.2%
COIN 18,499 27.4%
SDRL 11,086 15.0%
GPN 8,177 12.0%
Top Reduces (Value $000, Stocks/ETFs)
ILMN -60,717 -100.0%
CVS -44,696 -35.0%
NCLH -39,731 -31.2%
JD -31,404 -89.5%
IAC -27,849 -24.9%
UNH -25,630 -14.1%
UAL -19,975 -20.1%
DAL -17,353 -43.0%
C -16,511 -8.4%
FISV -16,316 -34.9%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 167,150 (5.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type